Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation

NCT06424236 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
TERMINATED
Status
73
Enrollment
OTHER
Sponsor class

Stopped DIAN-TU announced the discontinuation of the DIAN-TU-001 OLE based on the status of the drug program and findings from an interim efficacy analysis and.

Conditions

Interventions

Sponsor

Washington University School of Medicine

Collaborators